Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Gastric Cancer × rucaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 4 Fallopian Tube Neoplasms 4 Endometrial Neoplasms 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Urinary Bladder Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Recurrence 1 Prostate Cancer Metastatic 1 Mesothelioma, Malignant 1 Mental Retardation, X-Linked, With Or Without Seizures, Arx-Related 1 Leiomyosarcoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinosarcoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Endometrioid 1 Biliary Tract Neoplasms 1

Interventions

Oxaliplatin 5 Capecitabine 5 Paclitaxel 4 Fluorouracil 3 Docetaxel 3 Cisplatin 3 apatinib 2 S 1 (combination) 2 Leucovorin 2 titanium silicide 1 rucaparib 1 relatlimab 1 raltitrexed 1 pazopanib 1 olaparib 1 linrodostat 1 endostar protein 1 durvalumab 1 dacomitinib 1 capivasertib 1 camrelizumab 1 Sunitinib 1 Nivolumab 1 Ipilimumab 1 HMPL-013 1 Epirubicin 1 CF regimen 1 Bevacizumab 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02935634 2023-06-09

FRACTION-GC

Bristol-Myers Squibb

Phase 2 Completed

190 enrolled 25 charts

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡